Sara Cresta

2.6k total citations
55 papers, 1.3k citations indexed

About

Sara Cresta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sara Cresta has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Sara Cresta's work include Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (8 papers). Sara Cresta is often cited by papers focused on Cancer Treatment and Pharmacology (18 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (8 papers). Sara Cresta collaborates with scholars based in Italy, Switzerland and United States. Sara Cresta's co-authors include Luca Gianni, Cristiana Sessa, Giuseppe Capri, George D. Demetri, Antonella Perotti, Alberta Locatelli, Filippo de Braud, Grant A. McArthur, Stephan Dirnhofer and D. Bradley Koslin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Sara Cresta

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Cresta Italy	20	597	461	422	233	205	55	1.3k
Lorenzo D’Ambrosio Italy	18	590 1.0×	777 1.7×	337 0.8×	171 0.7×	138 0.7×	50	1.2k
Paolo Cotzia United States	17	363 0.6×	439 1.0×	364 0.9×	133 0.6×	149 0.7×	34	1.1k
Daniel Wai United States	22	514 0.9×	616 1.3×	945 2.2×	252 1.1×	109 0.5×	42	1.7k
Xiaopei Zhu United States	15	354 0.6×	484 1.0×	344 0.8×	172 0.7×	133 0.6×	22	1.1k
Hongying Zhang China	20	368 0.6×	751 1.6×	402 1.0×	209 0.9×	323 1.6×	83	1.3k
Svetlana Bolshakov United States	22	609 1.0×	738 1.6×	810 1.9×	334 1.4×	457 2.2×	31	1.9k
Henrik Lilljebjörn Sweden	22	338 0.6×	251 0.5×	588 1.4×	124 0.5×	184 0.9×	51	1.6k
Robert Nakayama Japan	21	496 0.8×	829 1.8×	697 1.7×	268 1.2×	303 1.5×	82	1.6k
Pierre‐Paul Bringuier France	15	406 0.7×	729 1.6×	398 0.9×	164 0.7×	103 0.5×	31	1.2k
Yoshiyuki Suehara Japan	23	863 1.4×	1.4k 3.1×	717 1.7×	244 1.0×	387 1.9×	113	2.2k

Countries citing papers authored by Sara Cresta

Since Specialization

Citations

This map shows the geographic impact of Sara Cresta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Cresta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Cresta more than expected).

Fields of papers citing papers by Sara Cresta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Cresta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Cresta. The network helps show where Sara Cresta may publish in the future.

Co-authorship network of co-authors of Sara Cresta

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Cresta. A scholar is included among the top collaborators of Sara Cresta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Cresta. Sara Cresta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rivoltini, Licia, Chiara Camisaschi, Giovanni Fucà, et al.. (2024). Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports. 14(1). 3379–3379. 6 indexed citations

Negrão, Marcelo V., Philippe A. Cassier, Benjamin Solomon, et al.. (2023). MA06.03 KontRASt-01: Preliminary Safety and Efficacy of JDQ443 + TNO155 in Patients with Advanced, KRAS G12C-Mutated Solid Tumors. Journal of Thoracic Oncology. 18(11). S117–S118. 16 indexed citations

Ambrosini, Margherita, Giovanni Fucà, Matteo Duca, et al.. (2021). Targeted protein degraders from an oncologist point of view: The Holy Grail of cancer therapy?. Critical Reviews in Oncology/Hematology. 169. 103532–103532. 4 indexed citations

Jhaveri, Komal, Dejan Juric, Sara Cresta, et al.. (2020). LBA1 Interim results of a phase I/Ib study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib (RIB) or alpelisib (ALP) in patients with ER+ breast cancer (BC) who had progressed after endocrine therapy (ET). Annals of Oncology. 31. S62–S62. 7 indexed citations

Mariani, Gabriella, Giulia Galli, Stefano Cavalieri, et al.. (2019). Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study. The Breast Journal. 25(2). 237–242. 3 indexed citations

Tessari, Anna, Lorenzo Pilla, Silvia Damian, et al.. (2018). Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?. The Breast. 42. 68–73. 27 indexed citations

Vernieri, Claudio, Michele Prisciandaro, Monica Milano, et al.. (2018). Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles. Clinical Breast Cancer. 19(2). e306–e318. 11 indexed citations

Fiedler, Walter, Sara Cresta, Henning Schulze‐Bergkamen, et al.. (2018). Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas. ESMO Open. 3(2). e000303–e000303. 12 indexed citations

Schöffski, Patrick, Sara Cresta, Ingrid A. Mayer, et al.. (2018). A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer. Breast Cancer Research. 20(1). 109–109. 67 indexed citations

10.

Mariani, Gabriella, Giulia Galli, Stefano Cavalieri, et al.. (2017). Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC). Annals of Oncology. 28. vi34–vi34. 1 indexed citations

11.

D’Ippolito, Elvira, Ilaria Plantamura, Lucia Bongiovanni, et al.. (2016). miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. Cancer Research. 76(18). 5562–5572. 72 indexed citations

12.

Cesne, Axel Le, Sara Cresta, Robert G. Maki, et al.. (2012). A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas. European Journal of Cancer. 48(16). 3036–3044. 109 indexed citations

13.

Sessa, Cristiana, Diégo Tosi, Lucia Viganò, et al.. (2009). Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel. Annals of Oncology. 21(6). 1315–1322. 47 indexed citations

14.

Sessa, Cristiana, Sara Cresta, Cristina Noberasco, et al.. (2009). Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours. European Journal of Cancer. 45(12). 2116–2122. 29 indexed citations

15.

Cresta, Sara, Cristiana Sessa, Carlo V. Catapano, et al.. (2008). Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours. European Journal of Cancer. 44(13). 1829–1834. 28 indexed citations

16.

Sessa, Cristiana, Antonella Perotti, Cristina Noberasco, et al.. (2008). Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer. European Journal of Cancer. 45(7). 1153–1161. 41 indexed citations

17.

Sessa, Cristiana, Antonella Perotti, Anna Lladó, et al.. (2007). Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule. Annals of Oncology. 18(9). 1548–1553. 37 indexed citations

18.

Sessa, Cristiana, Sara Cresta, Thomas Cerny, et al.. (2006). Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors. Annals of Oncology. 18(3). 561–568. 21 indexed citations

19.

Cresta, Sara, Giacomo Grasselli, Mauro Mansutti, et al.. (2004). A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer. Annals of Oncology. 15(3). 433–439. 29 indexed citations

20.

Perotti, Antonella, Sara Cresta, Giacomo Grasselli, et al.. (2003). Cardiotoxic effects of anthracycline–taxane combinations. Expert Opinion on Drug Safety. 2(1). 59–71. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact